Overview
- 18 inspections across 18 sites are on record.
- 14 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2014-04-11.
At a glance
Inspections
18
Sites
18
Observations
14
Career since
Feb 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| AstraZeneca UK Ltd | 11 Apr 2014 | Human Drugs | On file |
| Teva Operations Poland sp. z.o.o. | 28 Mar 2014 | Human Drugs | On file |
| G. Pohl-Boskamp GmbH & Co. KG | 22 Feb 2013 | Human Drugs | View 483 → |
| SPI PHARMA | 14 Feb 2013 | Human Drugs | On file |
| Alphapharm Pty Ltd | 17 Jun 2011 | View 483 → |
Sites inspected
AstraZeneca UK LtdMacclesfield, United Kingdom1 insp.
Teva Operations Poland sp. z.o.o.Krakow, Poland1 insp.
G. Pohl-Boskamp GmbH & Co. KGHohenlockstedt, Germany1 insp.
SPI PHARMASeptemes Les Vallons, France1 insp.
Alphapharm Pty LtdCarole Park, Australia1 insp.
Co-investigators
Investigators who share inspections with this person.
Anita R Michael5 shared
Nancy G Schmidt3 shared
Daryl A Dewoskin3 shared
Jose R Lopez2 shared
Rebecca Rodriguez1 shared
Full investigator report
Get the verbatim findings behind Marianela Aponte Cruz's 14 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site